The Most Important Hearing In Washington This Week – For Some Of Us, At Least
Executive Summary
Impeachment? That’s nothing compared to the chance to hear publicly from Stephen Hahn about what kind of US FDA Commissioner he might be.
You may also be interested in...
Hahn Confirmation Hearing: Solid Performance Light On Substance
US FDA commissioner nominee Stephen Hahn does not offer much detail on his policy positions; Senate confirmation could be completed by the end of the year.
US FDA Commissioner Nominee On Fast Track With Nov. 20 Hearing
Stephen Hahn will go before the Senate health committee less than three weeks after being nominated. Pink Sheet's historical charts illustrate how a long wait and a quick hearing could mean a rapid confirmation.
US FDA Alzheimer Guidance Update Reflects Changes In Biomarkers – And Leadership
Latest update to draft guidance on early Alzheimer’s drug development is the third iteration of a document first published in 2013. The history of the guidance is a reflection of structural and leadership changes in the neurology review team at FDA.